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Abstract
Matrix metalloproteinase-8, released mainly from neutrophils, is a critical regulator of the inflammatory response by its
ability to cleave multiple mediators. Herein, we report the results of a model of endotoxemia after intraperitoneal LPS
injection in mice lacking MMP-8 and their wildtype counterparts. Control, saline-treated animals showed no differences
between genotypes. However, there was an increased lung inflammatory response, with a prominent neutrophilic
infiltration in mutant animals after LPS treatment. Using a proteomic approach, we identify alarmins S100A8 and S100A9 as
two of the main differences between genotypes. Mice lacking MMP-8 showed a significant increase in these two molecules
in lung homogenates, but not in spleen and serum. Mice lacking MMP-8 also showed an increase in MIP-1a levels and a
marked activation of the non-canonical NF-kB pathway, with no differences in CXC-chemokines such as MIP-2 or LIX. These
results show that MMP-8 can modulate the levels of S100A8 and S100A9 and its absence promotes the lung inflammatory
response during endotoxemia.
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Introduction
The inflammatory response consists not only in local
inflammation. In severe cases, this response spreads from the
site of onset and evolves into a systemic injury [1]. In this setting,
the lungs are amongst the most commonly involved organs.
Neutrophils are recruited from the circulation [2], and a full-
blown immune response takes place in both the interstitium and
the alveolar spaces. This syndrome has been termed acute lung
injury and may result in a severe lung dysfunction by altering gas
exchange and respiratory mechanics. In patients with the
systemic inflammatory response syndrome, lung injury is related
to a high mortality rate [3].
The regulatory mechanisms responsible for the switch from a
local to a systemic response are only partially known. There is
increasing evidence that matrix metalloproteinases, a family of
enzymes with a great variety of substrates, may modulate the
inflammatory response by cleaving immune mediators and
regulating cell migration [4]. Matrix metalloproteinase-8, also
known as collagenase-2 or neutrophil collagenase, plays different
roles in the regulation of the inflammatory response [5]. Mice
lacking this enzyme show a delayed onset and also a slow
clearance of the local inflammatory infiltrates [6,7]. Several
immune mediators, such as MIP-1a [8], IL-10 [9] or LIX [10],
have been involved in this characteristic pattern and shown to be
substrates of MMP-8.
We hypothesized that MMP-8 plays also a role in the lung
response to endotoxemia. To test this hypothesis we used an
experimental model of inflammation by intraperitoneal injection
of lipopolysaccharide in wildtype and MMP-8 deficient mice.
After documentation of increased neutrophil recruitment in the
lungs from knockout mice compared to wildtype animals, we
used a proteomic approach to identify the molecules involved in
the observed differences in mice from both genotypes. These
studies revealed the alarmins S100A8 and S100A9, which are
significantly increased in mice lacking MMP-8, as two of the
candidates to be responsible for the increased inflammatory
response in mutant mice.
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Methods
Animals
Mice deficient in MMP-8 were generated as previously
described [6] and backcrossed to obtain a pure C57BL6
background. Normal mice with the same C57BL6 background
were used as wildtype counterparts. Seventy-two animals were
used in the study. Genotypes were confirmed by PCR in all
animals. Animals were kept in SPF conditions, with 12:12 hours
light/dark cycles and free access to water and food. All the
experimental protocols were reviewed and approved by the
University of Oviedo Animal Research Ethics committee.
Experimental Model
A dose of 5 mg/Kg of lipopolysaccharide (serotype O55:B5,
Sigma-Aldrich) was intraperitoneally injected to wildtype and
knockout mice. This dose induces lung inflammation with a peak
24 hours after injection [11]. Control animals from both genotypes
were injected only with vehicle (sterile saline). After 24 hours, mice
were anesthetized with a mixture of ketamine and xylazine, a
laparotomy was performed and the animals were sacrificed by
exsanguination. The lungs and the spleen were then removed. The
right lung and the spleen were frozen at 280uC for further
analysis. The left lung was fixated by intratracheal administration
of 4% formaldehyde and immersed in the same fixative. In
additional animals, a blood sample was obtained by cardiac
puncture.
Histological Study
Paraffin embedded sections were stained using a standard
hematoxylin-eosin technique. Three sections per mouse were
evaluated by two independent pathologists (AA, MSFG), blinded
to the experimental conditions. Each section was scored from 0 to
3 based on the septal thickening (grade 1), areas of alveolar
flooding (grade 2) and loss of normal alveolar structure (grade 3).
Lung neutrophil recruitment was evaluated by immunohisto-
chemical staining against myeloperoxidase (MPO) using an anti-
MPO antibody (Thermo Scientific). The number of MPO positive
cells in three randomly chosen high-power fields was counted and
averaged for each animal.
Bronchoalveolar Lavage
Four animals of each genotype were treated with LPS as
described. After 24 hours, mice were anesthetized and a
tracheostomy performed. Lungs were lavaged with three aliquots
(700 microliters) of sterile saline. Neutrophils in the recovered
bronchoalveolar lavage fluid (BALF) were counted in a hemocy-
tometer.
Flow Cytometry
For quantification of cell populations, additional mice from both
genotypes and treatments were studied. After sacrifice, the left
lung was washed in sterile PBS immediately after removal, cut in
sections and manually homogenized. The resulting extracts were
centrifuged, resuspended in 100 microliters of PBS and incubated
with fluorescence-labeled anti-CD45, antiCD11b, anti-Gr1 and
anti-Ly6G antibodies (BD Biosciences). Cell populations were
identified using a FACScanto flow cytometer (BD Biosciences).
DiGE Analysis
Lungs from WT and KO mice were perfused and then rinsed in
TAM (10 mM TRIS-HCl pH 8.5, 5 mM magnesium acetate) and
homogenized manually at room temperature in TUCT (7 M urea,
2 M tiourea, 4% CHAPS, 30 mM TRIS- HCl pH 8.5). 50 mg of
each sample were covalently labeled with 400 pmol of a specific
fluorophore (GE Healthcare): CyDye 3 (WT sample), CyDye 5
(KO sample) and CyDye 2 (pool of WT and KO sample 1:1).
Labeled samples were combined and UCDA (8 M urea, 4%
CHAPS, 130 mM DTT, 2% IEF buffer) was added in a 1:1 ratio.
Samples were isoelectrofocused (voltage in gradient for 26 hours at
18uC) in 24 cm pH 3–11 NL strips following manufacturer’s
instructions (GE Healthcare). Once the IEF step finished, strips
were equilibrated for 15 min in SES (6 M UREA, 30% glycerol,
2% SDS, 75 mM TRIS-HCl pH 6.8), 0.5% DTT and bromo-
phenol blue, and for another 15 minutes in SES+4.5%
iodoacetamide and bromophenol blue. Then, they were mounted
on top of a 13% SDS–PAGE with stacking gel in a Hoefer S600
apparatus (Ettan DALT Six, GE Healthcare). Electrophoresis was
performed at 80 V overnight in the dark at 18uC. After SDS–
PAGE, cyanine dye-labeled proteins were visualized directly by
scanning using a Typhoon 9400 imager (GE Healthcare). The
scanned gels were then directly analyzed with Progenesis Same-
Spots software (Nonlinear dynamics) and stained with SYPRO
Ruby (Molecular Probes).
Tryptic Digestion and MALDI-ToF Analysis
Differential spots were manually excised over a transilluminator.
Gel pieces were washed twice with 180 mL of 25 mM ammonium
bicarbonate/acetonitrile (70:30), dried for 15 min at 90uC, and
incubated with 12 ng/mL trypsin (Promega) in 25 mM ammoni-
um bicarbonate. The digestion was allowed to proceed for 1 h at
60uC. Peptides were purified with ZipTip C18 (Millipore) and
eluted with 1 mL of CHCA (a-cyano-4-hydroxycinnamic acid) to
be placed onto MALDI-ToFs plate. Once dried, they were
analyzed by mass spectrometry on a time-of-flight mass spectrom-
eter equipped with a nitrogen laser source (Voyager-DE STR,
Applied Biosystems). Data from 200 laser shots were collected to
produce a mass spectrum. Data explorer version 4.0.0.0 (Applied
Biosystems) was the software used to analyze the spectra.
Western Blotting
Tissues were homogenated in a standard RIPA buffer (100 mM
TRIS pH 7.4, 150 mM NaCl, 1 mM EDTA, 1% deoxycholic
acid, 1% Triton X-100, 0,25% SDS, 1 mM ortovanadate and a
protease inhibitor cocktail) and the protein content measured
(BCA kit, Pierce, USA). Twelve micrograms of protein or 4
microlitres of serum were loaded in 12% SDS-PAGE or 16.5%
Tris-tricine gels and electrophoresed. Then, proteins were
transferred to PVDF membranes, blocked in non-fat milk or
bovine albumin as needed, and incubated with antibodies against
S100A6 (R&D Systems), S100A8 (R&D Systems), S100A9 (R&D
Systems), MIP-2 (AbD serotec), LIX (Peprotech), MIP-1a
(Abcam), IL-10 (Abcam), p65 (phosphorylated and total, Abcam),
p52 (Cell signaling) and actin (Santa Cruz Biotechnology
#SC1616). Proteins were then detected by chemoluminiscence
(Millipore) using secondary peroxidase-linked antibodies. The
resulting images were acquired with a LAS-3000 camera and
analyzed using ImageJ software (NIH, USA).
Quantitative RT-PCR Analysis
RNA was extracted from frozen lung tissue using the Trizol
reagent. One microgram of RNA was used to synthesize cDNA
using superscript II reverse transcriptase following manufacturer’s
instructions. Then, a quantitative PCR was performed using 20 ng
of cDNA and TaqMan Universal PCR master mix and the specific
TaqMan probes for S100A8 (Mm00496696_g1) and S100A9
(Mm00656925_m1) genes (Applied Biosystems). These probes
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span along two exons of the gene, thus avoiding the amplification
of genomic DNA. Samples were studied in triplicate in an Applied
Biosystems 7300 real-time PCR system. Beta-actin was used as
control and the relative expression of the analyzed genes was
calculated according to manufacturer’s instructions.
Gelatin Zymography
Activity of matrix metalloproteinases 22 and 29 was measured
by standard gelatin zymography as previously described [12].
Briefly, lung homogenates were loaded in a 8% SDS-PAGE gel
containing 0.2% gelatin and electrophoresed. The gels were
washed in 2.5% Triton X-100 and incubated in a buffer (20 mM
TRIS, 5 mM CaCl2, pH 7.4). After staining with Commassie blue
and destaining with a methanol/acetic acid mixture, gelatinolytic
activity was identified as white bands over a blue background. Gels
were scanned and quantified using ImageJ software.
Statistical Analysis
Data are expressed as mean6SEM. Differences among groups
were evaluated using a two-way ANOVA, including genotype and
treatment (LPS or saline) as factors. Post-hoc tests were done using
the Bonferroni’s correction. A p value lower than 0.05 was
considered significant.
Results
Increased Lung Inflammatory Response in Mmp82/2
Mice
Seven LPS-treated and 7 saline-treated animals per genotype
were studied. Treatment with LPS induced histological lung injury
in both genotypes (Figure 1A–B), when compared to baseline
(p = 0.042 and p=0.001 for wildtype and knockout mice,
respectively). However, the severity of injury in knockout mice
doubled that from wildtype counterparts (p = 0.004 for the
difference between genotypes in LPS-treated animals). There
were no differences between genotypes in saline-treated animals.
Neutrophil infiltration within the lungs was measured by
counting MPO-positive cells in immunohistochemical prepara-
tions (n = 7/group, Figure 1C–D). As expected, there were no
differences in saline-treated animals. LPS administration induced a
small but significant increase in lung neutrophils in Mmp8+/+
animals (p,0.05 vs saline-treated wildtype mice), and a three-fold
higher increase in Mmp82/2 mice (p,0.001 vs saline treated
knockout mice, p,0.001 vs LPS-treated wildtype mice). There
were no differences in leukocyte populations measured by flow
cytometry or in the accumulation of myeloid-derived suppressor
cells (defined as CD45+, Gr1+, Mac-1+, 2862% vs 27,267%
after LPS in wildtype and knockout mice, respectively; n = 5/
group, p= 0.92). Neutrophil count in the BALF was also higher in
Mmp82/2 animals than in their wildtype counterparts (Figure 1E).
There were no differences in the number of macrophages (data not
shown). In spite of the differences in lung injury and inflammation,
there were no significant differences in survival between genotypes
(Figure 1F).
Proteomic Analysis of Lung Tissue
To identify MMP-8 substrates responsible for the differences in
leukocyte infiltration, lung tissue homogenates were analyzed
using 2D-DIGE (n= 4/group). Interestingly, members from the
S100 protein family, involved in the inflammatory response, were
identified, so we focused on these molecules as putative mediators
responsible for the differences. Figure 2 shows a representative 2D
gel (A) together with the protein spots (B) and confirmatory
western blots (C).
S100 Proteins are Increased in Lungs of MMP-8-deficient
Mice
To confirm the results of the proteomic analysis, we performed
western blot experiments using lung tissue homogenates (n = 7/
group) and antibodies against S100A6, S100A8 and S100A9.
There were no differences in S100A6 protein (Figure 3A, p= 0.45
in ANOVA). Regarding S100A8, we did not observe any
difference between genotypes in saline-treated animals, but a
significant increase after LPS injection (Figure 3B, p,0.001 and
p= 0.015 for wildtype and knockout mice respectively). Moreover,
S100A8 levels were significantly higher in knockout mice
(p = 0.004 for the difference between genotypes). S100A9 showed
a similar pattern (Figure 3C). Representative western blots are
presented in Figure 3D. S100A8 and S100A9 protein levels were
strongly correlated with the leukocyte count in histological sections
(correlation coefficients of 0.80 and 0.78 for S100A8 and S100A9
respectively, p,0.01 in both cases).
S100a8 and S100a9 gene expression was also studied by
quantitative PCR (n= 6/group). Crossing thresholds were
21.77961,048, 28.12560.702 and 27.06260.629 for actin,
S100a8 and S100a9 respectively. The results for each genotype
are shown in figure 3E. There were no differences between LPS-
treated wildtype and knockout mice (p = 0.531 and p= 0.776 for
S100A8 and S100A9 in the ANOVA, respectively).
Finally, we measured S100A8 and S100A9 levels in serum and
spleen homogenates to check if the differences observed in lung
tissue are a local phenomenon or the manifestation of a systemic
difference in alarmin levels. There were no differences in these two
molecules in serum or spleen (Figure 3F). These results suggest that
the differences observed in protein abundance are not caused by a
differential gene expression, but a different protein clearance in
lung parenchyma.
MMP-2 or MMP-9 do not Compensate the Absence of
MMP-8
As gelatinases MMP-2 and -9 have been involved in processing
of S100A8 and S100A9, we studied their levels by gelatin
zymography (n= 7/group, Figure 4). There was a non-significant
trend to higher levels of MMP-9 in lung tissue after LPS treatment,
with no differences between genotypes (p = 0.791 in ANOVA).
There were no differences in MMP-2 in response to LPS injection
in any of the genotypes. Figure 4C shows a representative
zymography.
Absence of MMP-8 affects Multiple Immune Mediators
It has been reported that MMP-8 can process a number of
immune mediators, including chemokines responsible for the
leukocyte infiltration. To study these factors that were not
identified by our proteomic approach, we measured the
abundance of MIP-1a, MIP-2 and LIX in lung tissue homoge-
nates (n = 7/group). MIP-1a increased in both genotypes after
LPS injection. This increase was more pronounced in mice lacking
MMP-8 (Figure 5A). In opposite, there were no differences
between genotypes in MIP-2 levels (Figure 5B). Likewise, we did
not observe changes in LIX abundance in any experimental group
(Figure 5C).
Activation of Non-canonical NF-kB Pathway in Mmp82/2
Mice
The NF-kB pathway is one of the main intracellular triggers of
the inflammatory response. Activation of this route was evaluated
by western blotting against p65 and p52 (markers of canonical and
non-canonical NF-kB pathway respectively). Seven mice per
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Figure 1. Lung inflammation during endotoxemia. N=7/group. LPS injection increases histological damage (A-B) and neutrophilic infiltration
(C-E). Mice lacking MMP-8 show a more severe injury with increased neutrophils within the lung tissue (C-D) and bronchalveolar lavage fluid (N= 4/
group, E). However, there were no differences in survival (F, n = 9 per genotype, log rank test p = 0.52). *p,0.05 in post-hoc tests.
doi:10.1371/journal.pone.0039940.g001
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group were studied. There were no differences between genotypes
in p65 phosphorylation (Figure 6A). However, there was a marked
activation of the non-canonical NF-kB pathway, demonstrated by
a 10-fold increase in p52 levels only in mice lacking MMP-8
(Figure 6B).
Discussion
Our results demonstrate that the absence of MMP-8 increases
the neutrophilic lung infiltration after LPS injection. This effect
could be explained by the accumulation of S100A8 and S100A9
proteins, in addition to other chemokines. These findings highlight
the central role of MMP-8 during the regulation of inflammatory
cell recruitment to the lungs by processing a variety of immune
mediators.
Matrix metalloproteinases have a wide range of substrates that
are responsible for their variety of effects. MMP-8, also known as
collagenase-2, has emerged as one of the most important
regulators of the inflammatory response [5]. Mutant mice lacking
MMP-8 show a characteristic inflammatory response, with an
initial delay in cell recruitment, but also with a later persistence of
the neutrophilic infiltration [6,13–15]. Therefore, absence of this
enzyme ameliorates hyperacute inflammation, but also worsens
the response later on [7]. Noteworthy, blood cell counts and the
migratory properties of neutrophils in knockout mice are normal
[8], so the differences between genotypes rely on the regulation of
the inflammatory response.
There are several molecular mechanisms that could be
responsible for these opposite effects of MMP-8. First, inflamma-
tory cells must degrade the extracellular matrix fibers in order to
migrate, so the collagenolytic activity must be essential for
neutrophils to reach the injured site [16]. Additionally, it has
been reported that this protease can cleave different chemokines
such as LIX [10,17] or MIP-1a [8]. By this proteolytic
inactivation, MMP-8 exerts an anti-inflammatory role. Finally,
MMP-8 also regulates neutrophil apoptosis, contributing to the
persistence of the infiltrate [18].
The results of the present study show that, in absence of MMP-
8, there is an accumulation of S100A8 and S100A9. These
myeloid-related proteins, included in the alarmins family, are
constitutively expressed in neutrophils, representing the 40–50%
of the cytoplasmic content [19], and released at the sites of injury.
By binding to RAGE and TLR4, they can trigger a proin-
flammatory response [20]. Both RAGE and TLR4 are widely
expressed in the lung tissue, so this pathway is of major relevance
during the alveolar inflammatory response after endotoxemia [21].
Figure 2. Proteomic identification of S100 proteins in lung from LPS treated animals. A 2D protein electrophoresis (DiGE) was performed
with samples from both genotypes (A). Differential spots corresponding to S100A6, S100A8 and S100A9 were identified (B) and validated by western
blotting (C). Red circles show the differential spots in 2D western blots.
doi:10.1371/journal.pone.0039940.g002
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Figure 3. Differential expression of S100 proteins between genotypes. N=7/group. The differences in S100A6 levels were not confirmed (A,
p = 0.45 in the ANOVA). However, S100A8 (B) and S100A9 (C) protein levels increased after LPS injection in both genotypes (p,0.05 in all post-hoc
tests). Mice lacking MMP-8 showed significantly higher levels of these two proteins than their wildtype counterparts (p,0.01 and p,0.001 for the
differences between genotypes in S100A8 and S100A9 respectively). Panel D shows representative western blots. However, S100A8 and S100A9 gene
expression was not different between genotypes during endotoxemia (n = 6/group, E). To discard systemic differences in alarmins, levels of S100A8
and S100A9 were measured in spleen homogenates (n = 7/group) and serum (n= 4/group) from LPS-treated animals, with no significant differences
between genotypes (F). *p,0.05 in post-hoc test.
doi:10.1371/journal.pone.0039940.g003
Figure 4. Absence of compensatory changes in MMP-9 (A) or MMP-2 (B) in mice lacking MMP-8 (n = 7/group). A representative
zymography is shown in panel C.
doi:10.1371/journal.pone.0039940.g004
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Figure 5. Chemokine levels in lung tissue. N = 7/group. LPS injection increased levels of MIP-1a (A, p,0.001 and p,0.001 for wildtype and
knockout mice), and MIP-2 (B, p,0.01 and p= 0.01 for wildtype and knockout mice) but not LIX (C, p = 0.56 in the ANOVA). Moreover, MIP-1a was
significantly higher in mice lacking MMP-8 (p,0.01 for the comparison between genotypes). *p,0.05 in post-hoc test.
doi:10.1371/journal.pone.0039940.g005
Figure 6. Non-canonical NF-kB activation in LPS-treated, Mmp82/2 mice. The lung levels of p52 increased significantly in knockout mice
after LPS challenge (n = 7/group, p = 0.01 vs saline-treated knockout mice, p,0.02 vs LPS-treated wildtype animals). *p,0.05 in post-hoc test.
doi:10.1371/journal.pone.0039940.g006
MMP-8 Mdulates S100A8/9 during Endotoxemia
PLoS ONE | www.plosone.org 8 June 2012 | Volume 7 | Issue 6 | e39940
Moreover, it has been demonstrated that both S100A8 and
S100A9 have chemotactic properties that favor neutrophilic
recruitment to the tissues [22]. Although S100A8 and S100A9
can also mediate the recruitment of myeloid-derived suppressor
cells [23], with anti-inflammatory properties, we did not find the
accumulation of these cells in the lung tissue in our model
irrespective of the genotype.
There is increasing evidence that MMPs can regulate the
alarmins/RAGE pathway by different mechanisms [24]. MMP-3
and -13 can release RAGE from alveolar epithelial cells [25]. The
resulting soluble RAGE could act as a decoy receptor with anti-
inflammatory properties. Although MMP-8 shares some structural
and functional characteristics with MMP-13 (both are interstitial
collagenases), the effects of the former on the release of RAGE
have not been addressed. Other MMPs, namely MMP-2 and
MMP-9 (gelatinases A and B respectively), can cleave and
inactivate S100A8 and S100A9. This mechanism limits the
inflammatory response in a model of lung allergic inflammation
[26]. The absence of compensatory changes in MMP-2 or MMP-9
supports the role of MMP-8 in the observed differences between
genotypes.
In this setting, MMP-8 appears as a central regulator of
neutrophilic chemotaxis by its effects on MIP-1a and alarmins.
Additionally, MMP-8 can modulate LIX activity and IL-10 levels,
as shown in other experimental models [6,9,10]. All these signals
may result in the activation of the NF-kB route. The chemotactic
activity of another RAGE and TLR ligand, HMGB1, has been
related to the activation of the non-canonical NF-kB pathway
[27]. Our results showing increased levels of p52 in mice lacking
MMP-8 resemble this finding. However, we cannot discard that
other factors not identified in our study are the cause of the
increase in NF-kB activity, as this is a final common pathway in
the inflammatory response.
The multiple and opposite effects of MMPs, and MMP-8 in
particular, can explain some contradictory results in the literature.
Absence of MMP-8 has been related to pro- and anti-inflamma-
tory responses. Regarding to MMP-8 and sepsis, all the
experimental models using LPS, either intratracheal [8,17] or
intraperitoneal (present study), report an increase in lung
inflammation in knockout mice. Recently, Solan et al. [28] have
shown the opposite effect (decreased neutrophilic infiltration and
better outcome in Mmp82/2 mice) in a model of cecal ligation
and puncture. The differences in the type and severity of injury
(with a survival rate in wildtype mice of 40% in our study, but 0%
in the peritonitis model), or the involvement of other mediators
such as IL-10 (which is increased in knockout mice [9]) may
explain these discrepancies. In human sepsis, MMP-8 correlates
with severity, mortality and organ failures [28,29]. Therefore,
targeting this enzyme could be an interesting therapeutic
approach. However, a deeper knowledge of the pro- and anti-
inflammatory effects of the enzyme is needed to make any firm
recommendation.
In conclusion, the results described here reinforce the central
role of MMP-8 in the regulation of neutrophil recruitment to the
lungs during sepsis, adding the myeloid-related proteins S100A8
and S100A9 as one of the involved mediators. This anti-
inflammatory role of MMP-8 must be considered before proposing
anti-MMP strategies in sepsis.
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